
    
      -  In patients with Essential hypertension to evaluate the efficacy and safety of
           Carvedilol SR (32mg, 64mg) or Carvedilol IR (25mg QD, 25mg BID) during 8 weeks.

        -  This study is consist of placebo run-in period(2~4 weeks_single blind) and treatment
           period(8 weeks_double blind).
    
  